Pricing Log in Create free account

Cognition Therapeutics, Inc. (CGTX) vs MindWalk Holdings Corp. (HYFT)

Cognition Therapeutics, Inc. and MindWalk Holdings Corp. are both Biotechnology companies. Cognition Therapeutics, Inc. and MindWalk Holdings Corp. are of similar size ($69.7M and $66.0M). Cognition Therapeutics, Inc. has the higher net margin (0.00% vs −105.1%) and the higher return on invested capital (0.00% vs −464.6%). Across the 14 metrics below, Cognition Therapeutics, Inc. leads on 9 and MindWalk Holdings Corp. on 5.

Valuation

Metric CGTX HYFT Biotechnology median
P/E n/m n/m 8.50
P/S n/m 5.23 9.71
P/B 2.00 12.39 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 5.14 9.21
Earnings yield (23.29%) (19.85%) (33.15%)
Free cash flow yield (26.75%) (14.68%) (25.50%)

Profitability

Metric CGTX HYFT Biotechnology median
Gross margin 0.00% 60.81% 65.16%
Operating margin 0.00% (103.99%) 0.00%
Net margin 0.00% (105.06%) 0.00%
Free cash flow margin 0.00% (76.79%) 0.00%
Return on equity (83.76%) (122.85%) (56.36%)
Return on assets (57.33%) (58.55%) (48.04%)
Return on invested capital 0.00% (464.59%) 0.00%

Growth

Metric CGTX HYFT Biotechnology median
Revenue growth (TTM) — (26.99%) 6.02%
EPS growth (last fiscal year) 62.79% 66.15% 30.26%
Revenue growth, 5-year CAGR — (3.83%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGTX HYFT Biotechnology median
Debt to equity 0.00 0.43 0.00
Current ratio 7.03 1.84 4.72
Net debt to EBITDA 0.78 0.62 0.96

Dividend

Metric CGTX HYFT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CGTX HYFT Biotechnology median
Market cap 69.67m 65.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack